Cargando…
Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
AIMS: Coronavirus disease 2019 (COVID-19) is rapidly spreading worldwide. Drug therapy is one of the major treatments, but contradictory results of clinical trials have been reported among different individuals. Furthermore, comprehensive analysis of personalized pharmacotherapy is still lacking. In...
Autores principales: | Wang, Lei-Yun, Cui, Jia-Jia, OuYang, Qian-Ying, Zhan, Yan, Wang, Yi-Min, Xu, Xiang-Yang, Yu, Lu-Lu, Yin, Hui, Wang, Yang, Luo, Chen-Hui, Guo, Cheng-Xian, Yin, Ji-Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283099/ https://www.ncbi.nlm.nih.gov/pubmed/34306260 http://dx.doi.org/10.1007/s13167-021-00247-0 |
Ejemplares similares
-
A Metabolomics Approach to Pharmacotherapy Personalization
por: Balashova, Elena E., et al.
Publicado: (2018) -
Toward a Personalized Pharmacotherapy of Respiratory Diseases
por: Montuschi, Paolo
Publicado: (2010) -
Pharmacotherapy for borderline personality disorder: A review
por: Lietor, M.D.C. Molina, et al.
Publicado: (2021) -
Tumor organoids for cancer research and personalized medicine
por: Yang, Hui, et al.
Publicado: (2022) -
Impact of Hospitalization on Antihypertensive Pharmacotherapy among Older Persons
por: Alhawassi, Tariq M., et al.
Publicado: (2015)